Amedisys Cash on Hand 2010-2024 | AMED

Amedisys cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Amedisys Annual Cash on Hand
(Millions of US $)
2023 $139
2022 $54
2021 $46
2020 $83
2019 $96
2018 $20
2017 $86
2016 $30
2015 $28
2014 $8
2013 $17
2012 $15
2011 $48
2010 $120
2009 $34
Amedisys Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $121
2023-12-31 $139
2023-09-30 $94
2023-06-30 $111
2023-03-31 $69
2022-12-31 $54
2022-09-30 $31
2022-06-30 $49
2022-03-31 $71
2021-12-31 $46
2021-09-30 $128
2021-06-30 $93
2021-03-31 $78
2020-12-31 $83
2020-09-30 $115
2020-06-30 $180
2020-03-31 $178
2019-12-31 $96
2019-09-30 $21
2019-06-30 $14
2019-03-31 $11
2018-12-31 $20
2018-09-30 $14
2018-06-30 $26
2018-03-31 $120
2017-12-31 $86
2017-09-30 $66
2017-06-30 $59
2017-03-31 $48
2016-12-31 $30
2016-09-30 $9
2016-06-30 $10
2016-03-31 $8
2015-12-31 $28
2015-09-30 $57
2015-06-30 $33
2015-03-31 $3
2014-12-31 $8
2014-09-30 $6
2014-06-30 $11
2014-03-31 $3
2013-12-31 $17
2013-09-30 $44
2013-06-30 $30
2013-03-31 $7
2012-12-31 $15
2012-09-30 $39
2012-06-30 $37
2012-03-31 $41
2011-12-31 $48
2011-09-30 $29
2011-06-30 $28
2011-03-31 $149
2010-12-31 $120
2010-09-30 $128
2010-06-30 $116
2010-03-31 $82
2009-12-31 $34
2009-09-30 $45
2009-06-30 $1
2009-03-31 $26
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.189B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.341B 0.00
Quest Diagnostics (DGX) United States $16.220B 16.76
DaVita (DVA) United States $12.098B 15.03
Encompass Health (EHC) United States $8.595B 22.00
Chemed (CHE) United States $8.221B 25.48
Elanco Animal Health (ELAN) United States $6.286B 16.31
Option Care Health (OPCH) United States $5.272B 19.95
RadNet (RDNT) United States $4.581B 95.39
Astrana Health (ASTH) United States $2.762B 37.37
Addus HomeCare (ADUS) United States $2.150B 27.83
LifeStance Health (LFST) United States $2.103B 0.00
U.S Physical Therapy (USPH) United States $1.423B 38.08
Pennant (PNTG) United States $0.815B 43.08
Aveanna Healthcare Holdings (AVAH) United States $0.662B 0.00
Atai Life Sciences (ATAI) Germany $0.248B 0.00
Daxor (DXR) United States $0.046B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.013B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00